Beovu vs. Lucentis

Reviewed on 12/11/2020

Are Beovu and Lucentis the Same Thing?

Beovu (brolucizumab-dbll) Injection and Lucentis (ranibizumab) Injection are used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD).

Beovu and Lucentis belong to different drug classes. Beovu is a human vascular endothelial growth factor (VEGF) inhibitor and Lucentis is a monoclonal antibody.

Side effects of Beovu and Lucentis that are similar include blurred vision.

Side effects of Beovu that are different from Lucentis include cataracts, bleeding in the eye, eye pain, and eye "floaters."

Side effects of Lucentis that are different from Beovu include discomfort and increased tears in the affected eye(s), itchy or watery eyes, dry eyes, swelling of the eyelids, sinus pain, sore throat, cough, and joint pain.

Both Beovu and Lucentis may interact with other drugs.

What Are Possible Side Effects of Beovu?

Common side effects of Beovu include:

  • blurred vision,
  • cataracts,
  • bleeding in the eye,
  • eye pain, and
  • eye "floaters"

What Are Possible Side Effects of Lucentis?

Common side effects of Lucentis include:

Lucentis may infrequently increase your risk for developing a certain serious eye condition (endophthalmitis), especially during the first week after receiving a dose. Tell your doctor if you notice symptoms in the affected eye(s) such as pain, redness, sensitivity to light, or a sudden change in vision.


Pink Eye (Conjunctivitis) Symptoms, Causes, Treatments See Slideshow

What Is Beovu?

Beovu (brolucizumab-dbll) Injection is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of Neovascular (Wet) Age-Related Macular Degeneration (AMD).

What Is Lucentis?

Lucentis (ranibizumab) Injection is a monoclonal antibody that works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels used to treat the wet form of age-related macular degeneration.

What Drugs Interact With Beovu?

Beovu may interact with other drugs. Tell your doctor all medications and supplements you use.

What Drugs Interact With Lucentis?

zOther drugs may interact with Lucentis. Tell your doctor all prescription and over-the-counter medications and supplements you use.

How Should Beovu be Taken?

Beovu is administered by intravitreal injection. The recommended dose for Beovu is 6 mg (0.05 mL of 120 mg/mL solution) monthly (approximately every 25-31 days) for the first three doses, followed by one dose of 6 mg (0.05 mL) every 8-12 weeks.

How Should Lucentis be Taken?

Lucentis is administered as an injection into the eye, with local anesthetic. It is done under physician supervision. Dose is 0.5 mg (0.05 mL) and is administered once a month.


What causes dry eyes? See Answer

All drug information provided on is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, makes every effort to update its drug information. Due to the time-sensitive nature of drug information, makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the or websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

Novartis. Beovu Product Information.

Genentech. Lucentis Product Information.

Health Solutions From Our Sponsors